Lucid Diagnostics Inc. (LUCD)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.7390 |
| Open | 0.7301 |
| Bid | 0.7063 x 200 |
| Ask | 0.7825 x 200 |
| Day's range | 0.7230 - 0.7482 |
| 52-week range | 0.6300 - 1.7210 |
| Volume | |
| Avg. volume | 221,271 |
| Market cap | 39.209M |
| Beta (5Y monthly) | 1.48 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.2600 |
| Earnings date | 26 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.75 |
PR Newswire4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that the 4,000th firefighter has undergone esophageal precancer testing using Lucid's EsoGuard® Esophageal DNA test as part of a #CheckYourFoodTube Precancer Testing Event. In partnership with physicians from Mass General Brigham, Boston's Local 718 International Association of Fire Fighte
- GuruFocus.com
Lucid Diagnostics Inc (LUCD) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...
Discover how Lucid Diagnostics Inc (LUCD) is navigating its financial landscape and strategic initiatives in the first quarter of 2024.
© 2024 Yahoo. All rights reserved.